Industries
Life Sciences
40+ years representing leading global life sciences & healthcare companies
Practices
-
Band 1for US Nationwide, California and Massachusetts Life Sciences in 2022 — ChambersTier 1for Healthcare: Life Sciences in 2021 — Legal 500 US#1consistent rank for global biotech & pharma licensing — BioPharm Insight#1in issuer-side life sciences IPOs since 2000#1for biotech and pharma venture financings for the last decade, including in 2018 — PitchBookTop 4law firm for US biotech & pharma M&A volume since 2016 (Mergermarket + Pitchbook)40+Dedicated, international practice group of 40+ professionals across the US, Europe and China exclusively focused on corporate partnering, licensing, M&A and other commercial transactions specific to life sciences companies"Highly Recommended” law firm for general corporate, licensing & collaborations, and M&A in 2019 — LMG Life Sciences
Band 1
for US Nationwide, California and Massachusetts Life Sciences in 2022 — Chambers
Tier 1
for Healthcare: Life Sciences in 2021 — Legal 500 US
#1
consistent rank for global biotech & pharma licensing — BioPharm Insight
#1
in issuer-side life sciences IPOs since 2000
#1
for biotech and pharma venture financings for the last decade, including in 2018 — PitchBook
Top 4
law firm for US biotech & pharma M&A volume since 2016 (Mergermarket + Pitchbook)
40+
Dedicated, international practice group of 40+ professionals across the US, Europe and China exclusively focused on corporate partnering, licensing, M&A and other commercial transactions specific to life sciences companies
"Highly Recommended” law firm for general corporate, licensing & collaborations, and M&A in 2019 — LMG Life Sciences
Cooley Rx
A virtual series focused on the life sciences and healthcare sectors
According to industry peers, the licensing, tax and inversion, private investment, capital market and M&A work performed by Cooley is top tier.
LMG Life Sciences